Pharma-Bio Serv (PBSV) Capital Expenditures Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 21.62% |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 6.16% |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 20.95% |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 30.88% |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -84.33% |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 111.15% |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 | -33.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -33.14% |
| Oct 31, 2025 | -69.33% |
| Jul 31, 2025 | -0.82% |
| Apr 30, 2025 | -0.79% |
| Oct 31, 2024 | 464.86% |
| Jan 31, 2024 | -31.65% |
| Oct 31, 2023 | -31.04% |
| Apr 30, 2023 | -69.73% |
| Jan 31, 2023 | -10.69% |
| Oct 31, 2022 | 9.94% |
| Jul 31, 2022 | -39.45% |
| Apr 30, 2022 | -50.41% |
| Jan 31, 2022 | -39.46% |
| Oct 31, 2021 | -26.28% |
| Apr 30, 2021 | -32.47% |
| Jan 31, 2021 | -63.10% |
| Oct 31, 2020 | 26.42% |
| Jul 31, 2020 | -36.34% |
| Apr 30, 2020 | -14.04% |
| Jan 31, 2020 | -65.70% |
| Oct 31, 2019 | -76.70% |
| Jul 31, 2019 | -72.75% |
| Apr 30, 2019 | -44.35% |
| Jan 31, 2019 | -80.48% |
| Oct 31, 2018 | -35.56% |
| Apr 30, 2018 | -41.81% |
| Jan 31, 2018 | 12.99% |
| Jul 31, 2017 | -27.45% |
| Apr 30, 2017 | -12.89% |
| Oct 31, 2016 | 154.16% |
| Jul 31, 2016 | 83.14% |
| Apr 30, 2016 | 124.73% |
| Jan 31, 2016 | 71.98% |
| Oct 31, 2015 | 96.71% |
| Jul 31, 2015 | -17.98% |
| Apr 30, 2015 | -27.59% |
| Jan 31, 2015 | 72.03% |
| Jul 31, 2014 | 246.68% |
| Apr 30, 2014 | 5.33% |
| Oct 31, 2013 | 35.17% |
| Jul 31, 2013 | 115.45% |